

Thymic epithelial cells (TECs) help orchestrate thymopoiesis, and TEC differentiation relies on bidirectional interactions with thymocytes. Although the molecular mediators that stimulate medullary thymic epithelial cell (mTEC) maturation are partially elucidated, the signals that regulate cortical thymic epithelial cell (cTEC) homeostasis remain elusive. Using IL-7 reporter mice, we show that TECs coexpressing high levels of IL-7 (Il7YFP+ TECs) reside within a subset of CD205+Ly51+CD40low cTECs that coexpresses Dll4, Ccl25, Ccrl1, Ctsl, Psmb11, and Prss16 and segregates from CD80+CD40high mTECs expressing Tnfrsf11a, Ctss, and Aire. As the frequency of Il7YFP+ TECs gradually declines as mTEC development unfolds, we explored the relationship between Il7YFP+ TECs and mTECs. In thymic organotypic cultures, the thymocyte-induced reduction in Il7YFP+ TECs dissociates from the receptor activator of NF-kB-mediated differentiation of CD80+ mTECs. Still, Il7YFP+ TECs can generate some CD80+ mTECs in a stepwise differentiation process via YFP2Ly51lowCD80low intermediates. Il7YFP+ TECs are sustained in Rag2-\- mice, even following in vivo anti-CD3 treatment that mimics the process of pre-TCR b-selection of thymocytes to the double positive (DP) stage. Using Marilyn-Rag2-\- TCR transgenic, we find that positive selection into the CD4 lineage moderately reduces the frequency of Il7YFP+ TECs, whereas negative selection provokes a striking loss of Il7YFP+ TECs. These results imply that the strength of MHC/peptide-TCR interactions between TECs and thymocytes during selection constitutes a novel rheostat that controls the maintenance of IL-7-expressing cTECs. © 2013 by The American Association of Immunologists, Inc.
| EMTREE drug terms: | autoimmune regulator proteinB7 antigenCcl25 proteinCcrl1 proteinCD205 antigenCD40 antigencell antigenCTSL proteinCtss proteinDLL4 proteinimmunoglobulin enhancer binding proteininterleukin 7Ly51 proteinPrss16 proteinPsmb11 proteinreceptor activator of nuclear factor kappa BT lymphocyte receptorunclassified drug |
|---|---|
| EMTREE medical terms: | animal cellanimal experimentanimal tissuearticleCD4+ T lymphocytecell differentiationcontrolled studyepithelium cellfemalehomeostasisin vivo studymajor histocompatibility complexmalemousenewbornnonhumanpriority journalprotein expressionregulatory mechanismthymic cortical epithelial cellthymocytetransgenic mouse |
| MeSH: | AnimalsAntigens, CDAntigens, CD3Antigens, CD40Antigens, CD80Cathepsin LCathepsinsCell DifferentiationCell MovementCells, CulturedChemokines, CCDNA-Binding ProteinsEpithelial CellsHomeostasisInterleukin-7Intracellular Signaling Peptides and ProteinsLectins, C-TypeLymphocyte ActivationMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutOrgan Culture TechniquesReceptor Activator of Nuclear Factor-kappa BReceptors, CCRReceptors, Cell SurfaceSerine EndopeptidasesThymocytesThymus GlandTranscription Factors |
APECED protein; Antigens, CD; Antigens, CD3; Antigens, CD40; Antigens, CD80; Cathepsin L, 3.4.22.15; Cathepsins, 3.4.-; Ccl25 protein, mouse; Chemokines, CC; Ctsl protein, mouse, 3.4.22.15; DEC-205 receptor; DLL4 protein, mouse; DNA-Binding Proteins; Interleukin-7; Intracellular Signaling Peptides and Proteins; Lectins, C-Type; Membrane Proteins; Prss16 protein, mouse, 3.4.21.-; Rag2 protein, mouse; Receptor Activator of Nuclear Factor-kappa B; Receptors, CCR; Receptors, Cell Surface; Serine Endopeptidases, 3.4.21.-; Tnfrsf11a protein, mouse; Transcription Factors; cathepsin S, 3.4.22.27
Alves, N.L.; Infection and Immunity Unit, CAGE Laboratory, University of Porto, Portugal;
© Copyright 2013 Elsevier B.V., All rights reserved.
© MEDLINE® is the source for the MeSH terms of this document.